Imatge de la portada

Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome

Introduction The purpose of this study was to determine the association between kisspeptin levels and obesity in patients with polycystic ovary syndrome (PCOS) or in healthy controls and to explore the correlation between levels of kisspeptin and various endocrine and metabolic indices in each group...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Meixiu Gao (Autor), Xinghua Tao (Autor), Qiong Zhang (Autor), Wenli He (Autor), Ting Zhao (Autor), Tao Yuan (Autor)
Format:	Llibre
Publicat:	Taylor & Francis Group, 2023-12-01T00:00:00Z.
Matèries:	article
Accés en línia:	Connect to this object online.
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome
per: Zhao Ting, et al.
Publicat: (2024)

Valproate Induced Obesity and Polycystic Ovaries
per: J Gordon Millichap
Publicat: (1996)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
per: Özlem Kayacık Günday, et al.
Publicat: (2023)

Altered expression of kisspeptin, dynorphin, and related neuropeptides in polycystic ovary syndrome: A cross-sectional study
per: Andon Hestiantoro, et al.
Publicat: (2024)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
per: Yazed Sulaiman Al-Ruthia, et al.
Publicat: (2017)

Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K/AKT/ERK signalling pathway
per: Pingping Sun, et al.
Publicat: (2023)

Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome
per: Cheng X, et al.
Publicat: (2022)

Prenatal kisspeptin antagonist exposure prevents polycystic ovary syndrome development in prenatally-androgenized rats in adulthood: An experimental study
per: Elahe Sadeghian Bakhi, et al.
Publicat: (2023)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
per: Hassan Kahal, et al.
Publicat: (2011)

Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study
per: Yuying Wang, et al.
Publicat: (2018)

Complications of Obesity in Polycystic Ovary Syndrome: Insulin Resistance and Inflammation
per: Sadaf Saleem Uppal, et al.
Publicat: (2024)

Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators
per: Xiao-li Li, et al.
Publicat: (2024)

Relationship between obesity and biochemical markers in Brazilian adolescents
per: Alexandre Romero, et al.
Publicat: (2014)

Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome
per: Cinar Nese, et al.
Publicat: (2012)

Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
per: Jin Ju Kim, et al.
Publicat: (2018)

Correlation between abnormal energy metabolism of ovarian granulosa cells and in vitro fertilization-embryo transfer outcomes in patients with polycystic ovary syndrome and obesity
per: Ya-Kun Zhao, et al.
Publicat: (2023)

New approaches to early detection of polycystic ovary syndrome in obese women
per: V.V. Artyomenko, et al.
Publicat: (2022)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
per: Joselyn Rojas, et al.
Publicat: (2014)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
per: Antoaneta Gateva, et al.
Publicat: (2012)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
per: Thomas M Barber, et al.
Publicat: (2019)

Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women
per: Po-Chun Ko, et al.
Publicat: (2015)

The effect of exercise on insulin resistance in obese women with polycystic ovary syndrome
per: Heba S Kareem, et al.
Publicat: (2014)

The Effect of Aerobic Exercise Training on Biochemical and Inflammatory Markers among Young Females Suffering from Polycystic Ovary Syndrome
per: Soheyla Jafari, et al.
Publicat: (2020)

The effect of oxytocin and Kisspeptin-10 in ovary and uterus of ischemia-reperfusion injured rats
per: M. Aslan, et al.
Publicat: (2017)

Polycystic ovary syndrome and circulating inflammatory markers
per: Farideh Zafari Zangeneh, et al.
Publicat: (2017)

Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art
per: I.A. Lapina, et al.
Publicat: (2021)

Pre-pregnancy preparation in women with polycystic ovary syndrome and obesity: state-of-the-art
per: I.A. Lapina, et al.
Publicat: (2021)

Kisspeptin and preeclampsia
per: Huann-Cheng Horng
Publicat: (2017)

A Comparative Study of Blood Levels of Manganese, Some Macroelements and Heavy Metals in Obese and Non-Obese Polycystic Ovary Syndrome Patients
per: Sarah H. Mhaibes, et al.
Publicat: (2017)

A Comparative Study of Blood Levels of Manganese, Some Macroelements and Heavy Metals in Obese and Non-Obese Polycystic Ovary Syndrome Patients
per: Sarah H. Mhaibes, et al.
Publicat: (2017)

Effects of an "Internet +" Multidisciplinary Management Model Oriented by Nurse Specialists on Obesity Combined with Polycystic Ovary Syndrome
per: Yuyi Ou, et al.
Publicat: (2023)

Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome
per: Funda Göde, et al.
Publicat: (2017)

"The whole package deal": experiences of overweight/obese women living with polycystic ovary syndrome
per: Carolyn Ee, et al.
Publicat: (2020)

The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
per: Akin Usta, et al.
Publicat: (2018)

Editor's Pick: Selection of Appropriate Tools for Evaluating Obesity in Polycystic Ovary Syndrome Patients
per: Yang Xu
Publicat: (2017)

The survey of central obesity and BMI associated with different phenotypes of polycystic ovary syndrome in adolescents
per: Marzieh Akbarzadeh, et al.
Publicat: (2015)

Evaluation of vitamin D status and its correlation with oxidative stress markers in women with polycystic ovary syndrome
per: Maryam Rahsepar, et al.
Publicat: (2017)

Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
per: Chih-Yuan Chang, et al.
Publicat: (2012)

Correlation of Kisspeptin-10 level and fetal well-being in preeclamptic patients
per: Maysoun A. Ziyaraa, et al.
Publicat: (2016)

Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome
per: Anil Satyaraddi, et al.
Publicat: (2019)